Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
Incyte Data at the European Academy of Dermatology and Venereology Congress Underscore the Breadth of Incyte's Inflammation and Autoimmunity Portfolio
Incyte Announces Funding of MINJUVI® for patients with Relapsed or Refractory Follicular Lymphoma through Ontario's FAST Program
Opzelura® Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers
Incyte Presents Phase 1/2 Multidose Data for VGA039 at ISTH 2026, Showing Substantial Bleed Reductions in Patients with all Von Willebrand Disease Types
Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Incyte Announces Positive CHMP Opinion for Opzelura® Cream for the Treatment of Adults with Moderate Atopic Dermatitis
Incyte Japan Announces Approval of Minjuvi® in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia
Results from Incyte's Pivotal Phase 3 frontMIND Trial of Tafasitamab Combination Presented at the 2026 European Hematology Association Congress Plenary Showed Prolonged Progression Free Survival
Renforth Resources Launches Research Collaboration with Queen's University on Low-Carbon Recovery of Critical Metals from the Victoria Deposit
